Correlation Between Sinphar Pharmaceutical and E Lead

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and E Lead at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and E Lead into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and E Lead Electronic Co, you can compare the effects of market volatilities on Sinphar Pharmaceutical and E Lead and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of E Lead. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and E Lead.

Diversification Opportunities for Sinphar Pharmaceutical and E Lead

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Sinphar and 2497 is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and E Lead Electronic Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on E Lead Electronic and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with E Lead. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of E Lead Electronic has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and E Lead go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and E Lead

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the E Lead. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 1.91 times less risky than E Lead. The stock trades about -0.07 of its potential returns per unit of risk. The E Lead Electronic Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  5,900  in E Lead Electronic Co on September 1, 2024 and sell it today you would earn a total of  550.00  from holding E Lead Electronic Co or generate 9.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.22%
ValuesDaily Returns

Sinphar Pharmaceutical Co  vs.  E Lead Electronic Co

 Performance 
       Timeline  
Sinphar Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
E Lead Electronic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days E Lead Electronic Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, E Lead is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Sinphar Pharmaceutical and E Lead Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinphar Pharmaceutical and E Lead

The main advantage of trading using opposite Sinphar Pharmaceutical and E Lead positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, E Lead can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in E Lead will offset losses from the drop in E Lead's long position.
The idea behind Sinphar Pharmaceutical Co and E Lead Electronic Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets